AXONIS team was seeking to add clarity when communicating with investors about their unique approach to spinal cord injury therapy. Spinal cord injury is not an easy disease to tackle, and neuron regeneration field didn’t see many successful ideas in the past.  

We worked closely with the CEO to thoroughly understand existing challenges with investors and took time to get to the bottom of the science that makes AXONIS’ approach different. We developed a new corporate story, messages, and content for the investor deck. Designed new mechanism of action illustrations to help the client explain the value of their scientific approach. And created a new logo and branding for this promising new startup.